2 completed, 2 unknown, 1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Cryoglobulinemic Vasculitis: new trials by email Literature Review of Cryoglobulinemic Vasculitis trials Research Report on Cryoglobulinemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isatuximab in Type I Cryoglobulinemia Isatuximab Injection - Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 21 | 2021-11-01 | 2021-11-09 |
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis | Phase 2 | Terminated | Cambridge University Hospitals NHS Foundation Trust | 22 | 2021-07-14 | 2025-06-17 |
| Journey of Patients With Vasculitis From First Symptom to Diagnosis Online Questionnaire - Vasculitis, Systemic Vasculitis | Completed | University of Pennsylvania | 456 | 2018-01-11 | 2018-06-06 | |
| Vasculitis Pregnancy Registry Online questionnaires - Vasculitis, Behcet's Disease | Recruiting | University of Pennsylvania | 100 | 2015-11-01 | 2026-01-23 | |
| Impact of Vasculitis on Employment and Income online questionnaire - Vasculitis, Systemic Vasculitis | Completed | University of South Florida | 426 | 2015-06-01 | 2016-01-28 | |
| Plasmapheresis Before Rituximab in Cryoglobulinemia Cryoglobulinemic Vasculitis | Unknown | University Hospital, Montpellier | 120 | 1999-01-01 | 2020-12-31 |
Cryoglobulinemia, Familial Mixed (6) · IgA Vasculitis (4) · Polyarteritis Nodosa (4) · Takayasu Arteritis (4) · Vasculitis (4) · Behcet Syndrome (3) · Giant Cell Arteritis (3) · Granulomatosis with Polyangiitis (3) · Microscopic Polyangiitis (3) · Systemic Vasculitis (3) · Vasculitis, Central Nervous System (3) · Churg-Strauss Syndrome (2) · Cogan Syndrome (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Multiple Myeloma (1)
Cardiovascular Diseases (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Hemorrhagic Disorders (5) · Hemostatic Disorders (5) · Immune System Diseases (5) · Vascular Diseases (5) · Aortic Arch Syndromes (4) · Aortic Diseases (4) · Arteritis (4) · Autoimmune Diseases (4) · Autoimmune Diseases of the Nervous System (4) · Blood Coagulation Disorders (4) · Brain Diseases (4) · Central Nervous System Diseases (4)
Infliximab (1) · Rituximab (1) · isatuximab (1) · tocilizumab (1)
University of Pennsylvania (2) · Assistance Publique - Hôpitaux de Paris (1) · Cambridge University Hospitals NHS Foundation Trust (1) · University Hospital, Montpellier (1) · University of South Florida (1)
United States (3) · France (1) · United Kingdom (1)
Peter A Merkel, MD, MPH (2) · Antoine Sreih, MD (1) · Christian Pagnoux, MD, MPH, MSc (1) · David Jayne (1) · Lillian Barra, MD, PhD (1) · Megan Clowse, MD, MPH (1) · Peter A. Merkel, MD, MPH (1)